ArteraAI vs Triomics
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. ArteraAI starts at See pricing page and Triomics starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
- Clinical trial matching
- Visit pre-charting
- Cancer registry abstraction
- Cited answers
- Whole-record reasoning
| Feature | ArteraAI | Triomics |
|---|---|---|
| Best for | AI pathology tests that predict cancer outcomes and therapy benefit | AI agents that read full cancer patient charts for trials and visits |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Artera | Triomics |
| Based in | United States | – |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
ArteraAI starts at See pricing page and Triomics starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Nov 5, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
ArteraAI
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
Triomics
- Reads the whole record, not one page
- Every answer cites its source
- Covers several oncology workflows
- Only for oncology
- No public pricing
- Enterprise sales process
Which one should you choose?
Choose ArteraAI if you want:
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Watch out: ordered by clinicians only.
Choose Triomics if you want:
- Reads the whole record, not one page
- Every answer cites its source
- Covers several oncology workflows
Watch out: only for oncology.
ArteraAI vs Triomics FAQ
What is the difference between ArteraAI and Triomics?
ArteraAI: AI pathology tests that predict cancer outcomes and therapy benefit. Triomics: AI agents that read full cancer patient charts for trials and visits. Both are legal, finance & hr tools.
Is ArteraAI or Triomics cheaper?
ArteraAI starts at See pricing page and Triomics starts at See pricing page. Check both pricing pages for current plans.
Do ArteraAI and Triomics have free plans?
ArteraAI: No. Triomics: No.
Who makes ArteraAI?
ArteraAI is made by Artera, based in United States.
Who makes Triomics?
Triomics is made by Triomics.
Which should I choose, ArteraAI or Triomics?
Choose ArteraAI if you value fda de novo authorization and listed in nccn prostate guidelines. Choose Triomics if you value reads the whole record, not one page and every answer cites its source.